Predictive oncology set to market ai drug discovery platform

Minneapolis, jan. 27, 2022 (globe newswire) -- predictive oncology inc. (nasdaq: poai) is set to be a first mover in the artificial intelligence (ai) powered drug discovery market that poai expects will grow to $20 billion in the next three years, reported the company today in outlining its strategy for 2022. the company plans to leverage its existing pharma relationships to market pedal™ in a move that will take the proprietary platform out of the research lab into the pipelines of oncology drug discovery companies.
POAI Ratings Summary
POAI Quant Ranking